Satsuma Pharmaceuticals Stock Number Of Employees
STSADelisted Stock | USD 1.10 0.01 0.90% |
Satsuma Pharmaceuticals fundamentals help investors to digest information that contributes to Satsuma Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Satsuma Stock. The fundamental analysis module provides a way to measure Satsuma Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Satsuma Pharmaceuticals stock.
Satsuma |
Satsuma Pharmaceuticals Company Number Of Employees Analysis
Satsuma Pharmaceuticals' Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Satsuma Pharmaceuticals Number Of Employees | 25 |
Most of Satsuma Pharmaceuticals' fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Satsuma Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
CompetitionBased on the recorded statements, Satsuma Pharmaceuticals is currently employing 25.0 people. This is 99.77% lower than that of the Pharmaceuticals sector and 95.33% lower than that of the Health Care industry. The number of employees for all United States stocks is 99.87% higher than that of the company.
Satsuma Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Satsuma Pharmaceuticals' direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Satsuma Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Satsuma Pharmaceuticals by comparing valuation metrics of similar companies.Satsuma Pharmaceuticals is currently under evaluation in number of employees category among its peers.
Satsuma Fundamentals
Return On Equity | -1.04 | |||
Return On Asset | -0.5 | |||
Current Valuation | (35.53 M) | |||
Shares Outstanding | 33.15 M | |||
Shares Owned By Insiders | 10.43 % | |||
Shares Owned By Institutions | 57.90 % | |||
Number Of Shares Shorted | 130.12 K | |||
Price To Earning | 22.12 X | |||
Price To Book | 0.42 X | |||
EBITDA | (58.31 M) | |||
Net Income | (70.06 M) | |||
Cash And Equivalents | 68.06 M | |||
Cash Per Share | 2.15 X | |||
Total Debt | 205 K | |||
Debt To Equity | 0 % | |||
Current Ratio | 9.18 X | |||
Book Value Per Share | 1.14 X | |||
Cash Flow From Operations | (51.52 M) | |||
Short Ratio | 0.05 X | |||
Earnings Per Share | (1.99) X | |||
Price To Earnings To Growth | 4.50 X | |||
Target Price | 2.0 | |||
Number Of Employees | 25 | |||
Beta | 0.1 | |||
Market Capitalization | 36.8 M | |||
Total Asset | 54.94 M | |||
Retained Earnings | (211.79 M) | |||
Working Capital | 46.69 M | |||
Z Score | 99.83 | |||
Net Asset | 54.94 M |
About Satsuma Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Satsuma Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Satsuma Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Satsuma Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Satsuma Stock
If you are still planning to invest in Satsuma Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Satsuma Pharmaceuticals' history and understand the potential risks before investing.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Stocks Directory Find actively traded stocks across global markets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |